Related Experiment Video
Updated: Mar 28, 2026

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
AutoML-Multiverse: An Instability-Aware Framework for Quantifying Analytic Variability in Alzheimer's Disease
Maitrei Kohli1, Gonzalo Castro Leal1, Douglas Wyllie1,2
1UCL Hawkes Institute, University College London, London, UK.
Machine learning models for Alzheimer's disease (AD) can be unreliable due to analysis choices. AutoML-Multiverse addresses this by exploring thousands of analysis pipelines, improving the robustness of AD prediction models.
Area of Science:
- Artificial Intelligence
- Computational Neuroscience
- Biomedical Informatics
Background:
- Machine learning (ML) models for Alzheimer's disease (AD) often produce inconsistent results, impacting their reliability and interpretability.
- Analytic variability and researcher biases contribute to the instability of ML models in AD research.
- Clinical heterogeneity and cohort differences further complicate the development of robust AD prediction models.
Purpose of the Study:
- To introduce AutoML-Multiverse, a novel framework designed to characterize how analytical choices influence ML conclusions in AD research.
- To systematically quantify analytic instability in clinical ML models for AD.
- To improve the robustness and clinical applicability of ML-based prediction models for Alzheimer's disease.
Main Methods:
- Explored a vast space of approximately 20,000 analysis pipelines using the AutoML-Multiverse framework.
- Evaluated the framework across 20 classification tasks in two independent Alzheimer's disease progression cohorts (ADNI and NACC).
- Utilized multiple data modalities including neuroimaging, clinical/cognitive data, and fluid biomarkers.
Main Results:
- AutoML-Multiverse demonstrated performance equal to or better than non-automated models across all classification tasks.
- Classification accuracy for stable vs. progressive mild cognitive impairment (MCI) was 0.68±0.06 (ADNI) and 0.63±0.08 (NACC).
- Accuracy for Alzheimer's disease (AD) vs. cognitively normal (CN) classification reached 0.97±0.01 (ADNI), with modality utility varying by task and cohort.
Conclusions:
- Analytic choices significantly impact ML model rankings and biomarker importance in AD research.
- Cross-cohort variability underscores the limitations of single-dataset studies and highlights the need for instability-aware evaluation.
- The AutoML-Multiverse framework enhances the robustness of AI-driven research by reducing analysis-driven variability and characterizing uncertainty.
More Related Videos
06:41Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)
Published on: January 10, 2025
06:46Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage
Published on: August 4, 2018
Related Concept Videos
Variability: Analysis
The range is a simple measure of variability, indicating the difference between the highest and...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Statistical Analysis: Overview
One of the most commonly used statistical quantifiers is the mean, which is the ratio between the sum of the numerical values of all results and the...
Quantitative Analysis
In quantitative analysis, two key measurements are made: the sample quantity and a property proportional to the amount of the analyte (the substance being analyzed). This forms the basis of the...
Stability of structures
Survival Tree
Building a Survival Tree
Constructing a...